Gerald Bagg serves as Executive at Cure Pharmaceutical Holding Corp., where they oversee executive responsibilities. Since joining the company, Gerald Bagg has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 25, 2022 involved receiving (via award) 220,795 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 25, 2022 | CURR | $0 | Award | 220,795 | $N/A | Discretionary |
Gerald Bagg currently holds 220,795 shares of Cure Pharmaceutical Holding Corp. (CURR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gerald Bagg has been a net neutral trader of CURR stock. They have purchased $0 and sold $0 worth of shares.
Gerald Bagg's most recent insider trade was on Jul 25, 2022, when they sold 220,795 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted